Chinese Journal of Tissue Engineering Research ›› 2011, Vol. 15 ›› Issue (49): 9231-9234.doi: 10.3969/j.issn.1673-8225.2011.49.026

Previous Articles     Next Articles

Expression of cancer-testis antigen in glioma stem cells

Tang Jing-Feng1, Xiao Shao-wen2, Huang Yong-wang1, Yang Bao-hua1, Du Yi-qing1   

  1. 1Department of Neurosurgery, Affiliated Hospital of Guilin Medical College, Guilin  541001, Guangxi Zhuang Autonomous Region, China
    2Department of Neurosurgery, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
  • Received:2011-04-14 Revised:2011-06-22 Online:2011-12-03 Published:2011-12-03
  • About author:Tang Jing-feng★, Master, Associate chief physician, Department of Neurosurgery, Affiliated Hospital of Guilin Medical College, Guilin 541001, Guangxi Zhuang Autonomous Region, China tangjingfeng152@163.com

PDF

294

Abstract:

BACKGROUND: It is still unclear on the expression of cancer-testis antigen genes in glioma stem cells.
OBJECTIVE: To detect the expression of cancer testis antigen genes in glioma stem cells.
METHODS: Stem cells were cultured and isolated by neurosphere culture methods in DMEM/F12. Then the expression of cancer testis antigen genes were analyzed among parent cells, stem cells and differentiated cells by using semiquantitative RT-PCR and real time PCR.
RESULTS AND CONCLUSION: We isolated tumor spheres from glioma cell lines by neurosphere culture. And then tumor spheres were cultured in medium containing serum, the morphology of the tumor spheres changed to adherent and they were not distinguishable from the parent cells. The expression of cancer testis antigen genes were analyzed by semiquantitative RT-PCR and quantitative RT-PCR and it was found that the expression were highest in stem cells compared with parent cells and differentiated cells. Cancer testis antigen genes may present as surface antigens in cancer stem cells and these findings suggest that cancer testis antigen genes may be helpful for targeted vaccine therapy against cancer stem cells in glioma patients.

CLC Number: